Is a 97.9% result from Medutest comparable to 98.4% from PeptideMeter?

Stated plainly: 97.9% · Medutest · 98.4% · PeptideMeter.

Both of these get recommended confidently by different people, which suggests neither is obviously right.

My constraints are cost, measurement resolution and how much handling I am prepared to do — in roughly that order.

Is there a defensible reason to prefer one, or is this a coin flip?

97.9 and 98.4 are 0.5 percentage points apart, which sounds small until you restate it as impurity. Medutest is leaving 2.1 per cent of the detected area unassigned and PeptideMeter 1.6 per cent — a factor of 1.31 between them. The impurity fraction is the quantity that moves when a method changes, and it is the one worth arguing about; the headline is just its complement. Comparable means same column chemistry, same gradient slope, same detection wavelength, same integration convention. Until you have those four from both laboratories, 97.9 and 98.4 are two measurements of slightly different quantities that happen to share a unit.

The honest answer is that the achievable range of plausible purity figures for a given vial is wider than most people expect.

Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.

What each test answers

Concretely, sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

Compare purity within a single laboratory on the same method, never across laboratories.

Start from what the detector sees, because that tells you what the number means.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

Integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

edited 8 Jul 2025 by s_kalniete — added a caveat about sampling

The short answer is that two competent laboratories on identical material will disagree, and the disagreement is almost always explainable by method differences.

Retention time is sequence-specific and method-specific, so comparing your result to a supplier value using a different method is meaningless without method documentation.

Concretely, mobile phase additive choice affects ionisation and peak shape — TFA gives sharp peaks but suppresses mass spectrometry signal, formic acid gives worse peaks but preserves signal.

The Arrhenius relationship for peptide degradation is the basis of accelerated stability testing and also governs how quickly methods drift with temperature.

If you are ranking vendors, specify a method and have all samples tested at the same place.

The underlying point is that purity is a method-dependent figure, and that is not a limitation of the measurement, it is a property of what the measurement actually answers.

The fraction of your main peak that is actually your target versus isomers, fragments or related sequences is invisible without complementary identity testing.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

In practice, the method matters more than the vial, which is why specifying a method buys you far more than changing suppliers does.

Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.